Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125488221 | 12548822 | 1 | I | 20160629 | 0 | 20160711 | 20160711 | DIR | 70.33 | YR | M | N | 105.90000 | KG | 20160708 | N | MD | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125488221 | 12548822 | 1 | PS | CYTARABINE. | CYTARABINE | 1 | 0 | 13860 | MG | ||||||||||
| 125488221 | 12548822 | 2 | SS | IDARUBICIN | IDARUBICIN | 1 | 0 | 84 | MG | ||||||||||
| 125488221 | 12548822 | 3 | SS | PRAVASTATIN SODIUM. | PRAVASTATIN SODIUM | 1 | 0 | 10240 | MG |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125488221 | 12548822 | HO |
| 125488221 | 12548822 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125488221 | 12548822 | Fall | |
| 125488221 | 12548822 | Laceration | |
| 125488221 | 12548822 | Neutrophil count decreased | |
| 125488221 | 12548822 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 125488221 | 12548822 | HP |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125488221 | 12548822 | 1 | 20160609 | 0 | ||
| 125488221 | 12548822 | 2 | 20160608 | 0 | ||
| 125488221 | 12548822 | 3 | 20160610 | 0 |